Further, Zimura is being evaluated as combination therapy with Eylea, an anti-VEGF agent, in patients with idiopathic polypoidal choroidal vasculopathy.
[6] ICG may also be performed to diagnose an atypical form of nAMD known as idiopathic polypoidal choroidal vasculopathy (IPCV), (7-9) in which a branching vascular complex forms within the choroid, terminating in polypoidal dilations (polyps) at the edge of the lesion.